Overview

This book begins by providing an overview of clinical biobanks, including their connotation, development process, standard establishment, and prospects. The general section then delves into various aspects of clinical biobanks from both management and technological perspectives, such as overall planning, infrastructure and security, full-process construction and management, informationization construction, quality control system, standard system, ethical construction, and relevant laws and regulations. Finally, the specific section systematically summarizes and highlights the principles and contents of constructing a biobank for representative major diseases and chronic diseases. These include cerebrovascular diseases, cardiovascular diseases, Parkinson's disease, mental disorders, diabetes, chronic kidney diseases, orthopedic diseases, hepatitis B and AIDS, tuberculosis, emerging and outbreak infectious diseases, common malignant tumors, childhood leukemia, esophageal cancer and precancerous lesions, gastrointestinal tumors, and gynecologic tumors

Full Product Details

Author:   Wang Xiaomin ,  Gao Hengjun
Publisher:   Springer Verlag, Singapore
Imprint:   Springer Verlag, Singapore
Edition:   1st ed. 2024
ISBN:  

9789819937417

ISBN 10:   9819937418
Pages:   379
Publication Date:   27 May 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Forthcoming
Availability:   Not yet available  
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Table of Contents

Part 1: An Overview of Clinical Biological Sample Database.- Chapter 1. Definition and Development of a Clinical Biobank.- Chapter 2. The Establishment of Standards, a Clinical Biobank Milestone.- Chapter 3. Prospects for the Sustainable Development of Clinical Biobanks.- Part 2: General Introduction to the Database of Clinical Biological Samples.- Chapter 4. Overall Planning for Clinical Biobanks.- Chapter 5. Constructing and Guaranteeing an Infrastructure for Clinical Biobanks.- Chapter 6. The Whole Period Establishment and Lifecycle Management of Clinical Samples.- Chapter 7. Establishing the Biobank Information Management System.- Chapter 8. The Quality Control System of Clinical Biobanks.- Chapter 9. The Establishment and Application of the Standardized System in Clinical Biobanks.- Chapter 10. The Establishment and Application of Standard Assessment Systems of Clinical Biobanks.- Chapter 11. Ethical Issues in the Establishment of Clinical Biobanks.- Chapter 12. Laws and Regulations for the Construction of Clinical Biobanks—Management and Implementation of Access to Human Genetic Resources.- Chapter 13. Construction, Management, and Application of Applied Omics Information in Biobanks.- Chapter 14. Integration, Mining and Analysis of Clinical Data and Bioinformatic Data.- Part 3: Theories of Clinical Biobanks.- Chapter 15. The Biobank for Cerebrovascular Disease.- Chapter 16. Biobanks for Cardiovascular Disease.- Chapter 17. Biobanks for Parkinson’s Disease.- Chapter 18. Biobanks for Menta Health Disorders.- Chapter 19. The Biobank for Diabetes Mellitus.- Chapter 20. The Biobank for Chronic Kidney Disease.- Chapter 21. Orthopedic Disease Biobanks.- Chapter 22. Hepatitis B-Related Liver Diseases and AIDS Biobank.- Chapter 23. The Biobank for Tuberculosis.- Chapter 24. The Biobank of Emerging Infectious Diseases.- Chapter 25. The Biobank for Common Malignant Tumors Chapter.- Chapter 26. Childhood Leukemia Biobanks.- Chapter 27. EsophagealCancer and Precancerous Lesions Biobank.- Chapter 28. Gastrointestinal Tumor Biobanks.- Chapter 29. Gynecological Tumor Sample Bank.- Appendix.

Reviews

Author Information

Prof. Wang Xiaomin, MD and PhD, Vice president of Capital Medical University, Dean of Department of Neurobiology, Capital Medical University, Director of Beijing Institute for Brain Disorders, Chief scientist of Beijing Biobank for major diseases, the Council member of the International Society for Biological and Environmental Repositories (ISBER), Chairman of China region. Prof. Gao Hengjun, MD and PhD, Director of Shanghai National Engineering Research Center for Biochip, Director of Shanghai Molecular Medicine Engineering Technology Research Center, Director of the Institute of Digestive Diseases, Tongji University School of Medicine, Chairman of the National Committee for Standardization of Biological samples, Chairman of the Biological Sample library branch of China Pharmaceutical Biotechnology Association, professor and chief physician. 

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions